1/7
04:23 pm
ikt
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: Iwicki Mark T
High
Report
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: Iwicki Mark T
1/7
04:22 pm
ikt
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: Cabell Christopher
High
Report
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: Cabell Christopher
1/7
04:18 pm
ikt
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: McIntyre David
High
Report
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: McIntyre David
12/31
05:01 pm
ikt
Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: Trails Edge Capital Partners, LP
Medium
Report
Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: Trails Edge Capital Partners, LP
12/19
04:18 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Dec 19
Medium
Report
Form 8-K Inhibikase Therapeutics, For: Dec 19
12/19
04:15 pm
ikt
Form 424B5 Inhibikase Therapeutics,
Medium
Report
Form 424B5 Inhibikase Therapeutics,
11/24
03:47 pm
ikt
Form 4 Inhibikase Therapeutics, For: Nov 21 Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
Low
Report
Form 4 Inhibikase Therapeutics, For: Nov 21 Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
11/21
04:28 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Nov 20
Medium
Report
Form 8-K Inhibikase Therapeutics, For: Nov 20
11/21
04:24 pm
ikt
Form 424B5 Inhibikase Therapeutics,
Medium
Report
Form 424B5 Inhibikase Therapeutics,
11/20
04:35 pm
ikt
Form 424B5 Inhibikase Therapeutics,
Medium
Report
Form 424B5 Inhibikase Therapeutics,
11/20
04:12 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Nov 20
Medium
Report
Form 8-K Inhibikase Therapeutics, For: Nov 20
11/14
04:43 pm
ikt
Form 10-Q Inhibikase Therapeutics, For: Sep 30
Low
Report
Form 10-Q Inhibikase Therapeutics, For: Sep 30
11/14
04:31 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Nov 14
Low
Report
Form 8-K Inhibikase Therapeutics, For: Nov 14